Introduction {#cesec10}
============

In most high-income countries, tobacco smoking prevalence and the associated burden of mortality and disease[@bib1] are greater in groups with lower socioeconomic position.[@bib2] Socioeconomic position refers to the social and economic circumstances that influence how different people are positioned within the structure of society.[@bib3] In England, for example, smoking prevalence is 22·8% among those with manual occupations compared with 12·7% among those with professional to clerical occupations.[@bib4] These results are supported by observations according to relative socioeconomic position in other high-income, middle-income, and low-income settings.[@bib5], [@bib6], [@bib7]

Research in context**Evidence before this study**We searched MEDLINE, PsycINFO, Embase, Cochrane Central Register, and Tobacco Addiction Register of Clinical Trials and the IC-SMOKE project database for studies published in English from database inception until Aug 18, 2019, with the following search terms: smoking cessation or smok\* quit\* or smok\* stop\* or smok\* cease or smok\* cessat\* or smok\* give up (title and abstract); systematic review or review or RCT or randomi?ed controlled trial or trial or randomi?ed or pragmatic clinical trial (title and abstract); behavio\* or behavio?ral support or intervention or counsel\* or brief or support or psychol\* or individual\* or individual-level or behavio?r therapy or cognitive therapy or target\* or adapt\* or tailor\*) not pharma\* (title and abstract); and equity or equity impact or inequalit\* or poor or disparit\* or SES or socio-economic or socio-economic or depriv\* or disadvant\* social class or occupation or employ or unemploy\* or educat\* or income or poverty. Tobacco control experts from the authors' institution and others working within the UK Centre for Tobacco and Alcohol Studies were consulted about relevant submitted or in press articles. Several Cochrane reviews focused on individual-level interventions that were not tailored for low socioeconomic position, including motivational interviewing, behavioural support, and different uses of pharmacotherapy. Bauld and colleagues (2010) examined the equity effect of non-socioeconomic-position-tailored interventions. Reviews by Murray and colleagues (2009) and Bryant and colleagues (2011) focused on interventions targeted at disadvantaged smokers. These reviews suggested that, despite behavioural interventions showing promise for reducing inequalities, smoking cessation generally remains lower among disadvantaged groups. However, these reviews did not examine whether socioeconomic position tailoring moderated intervention effectiveness compared with non-socioeconomic-position-tailored approaches.**Added value of this study**To our knowledge, no previous reviews have extended examination of the overall effect of all types of individual-level interventions for smoking cessation in socioeconomically disadvantaged groups to also consider whether socioeconomic position tailoring moderates this effectiveness. We found that both socioeconomic-position-tailored and non-socioeconomic-position-tailored individual-level interventions were effective for smoking cessation in disadvantaged groups. However, there were no large moderating effects of tailoring the interventions for disadvantaged groups compared with not tailoring the interventions. This analysis is an important step forward in gathering evidence about the effectiveness of tailored approaches and encourages further research to improve the effectiveness of equity-focused smoking cessation programmes.**Implications of all the available evidence**This systematic review and meta-regression highlights the challenges in achieving improved long-term smoking cessation in disadvantaged groups through tailoring of interventions. Our results do not imply that socioeconomic-position-tailored approaches should be abandoned, but rather that to improve rates of smoking cessation among disadvantaged smokers new, multifaceted approaches are required at the individual, community, and population level, recognising the wider context of socioeconomically disadvantaged smokers. Further research should assess whether current interventions could be further adapted and improved to extend the benefits into longer-term success over and above the effectiveness of non-socioeconomic-position-tailored approaches.

Regular smoking is established and maintained by a variety of molecular and behavioural factors linked to the rapid release of nicotine from cigarettes.[@bib8], [@bib9] Along with other WHO Framework Convention on Tobacco Control measures,[@bib10] individual-level interventions play an important part in disrupting this motivational process[@bib11] to support a successful quitting attempt.[@bib12] However, even with the best support, long-term quitting rates remain low.[@bib13] Interventions that are tailored to smokers from disadvantaged groups stem from the recognition that smokers from disadvantaged groups have greater difficulty in quitting and remaining abstinent[@bib14] than do those from more affluent groups. Behavioural interventions delivered at the individual level that recognise the wider context of socioeconomically disadvantaged smokers might prove more successful.[@bib15], [@bib16]

The terms socioeconomic position and disadvantaged were operationalised in this Article as populations facing inequalities, marginalisation, or disadvantage in terms of social class, occupation, unemployment, income, poverty, or residential neighbourhood.[@bib15] In many contexts, ethnicity can change the probability of being socioeconomically disadvantaged.[@bib17] Some socioeconomic-position-tailored interventions might be delivered to mostly ethnic minority participants---for example, the African American community in the USA. However, given the variety of ethnic distributions and degrees of stigmatisation and the fact that tailoring usually involves some additional cultural adaptation, including such studies was beyond the scope of this Article.

In theory, tailoring interventions to participant characteristics can enhance effectiveness by relating to a participant\'s life and needs or overcoming specific obstacles to achieve a desired change.[@bib18] In this Article, we assessed interventions according to whether or not they were tailored to socioeconomic position. Socioeconomic-position-tailored interventions are developed specifically for individuals from socioeconomically disadvantaged groups and aim to overcome some of the specific barriers to quitting that smokers from these groups face, such as financial stress, absence of social support, addiction, insufficient self-efficacy, stress, scarce life opportunities, and little interest in and understanding of tobacco harms.[@bib2] By contrast, non-socioeconomic-position-tailored interventions are not designed specifically for disadvantaged groups.[@bib19] In some instances, non-socioeconomic-position-tailored interventions are delivered in a disadvantaged context where recipients have low socioeconomic position, but this does not constitute socioeconomic position tailoring because the intervention has not been developed specifically for such recipients.

Previous reviews have examined the equity effect of non-socioeconomic-position-tailored interventions[@bib20] or focused on interventions targeted towards disadvantaged smokers.[@bib21], [@bib22] These reviews suggest that despite behavioural interventions showing promise for reducing inequalities, smoking cessation prevalence generally remains lower among disadvantaged groups.[@bib22], [@bib23] A review of research outputs concluded that current research was insufficient to encourage equity-positive improvements in smoking cessation.[@bib24] To our knowledge, no previous reviews have extended examination of the overall effect of all types of individual-level interventions for smoking cessation in socioeconomically disadvantaged groups to also investigate whether socioeconomic position tailoring moderates this effectiveness.

If socioeconomic-position-tailored interventions are not markedly more effective than non-socioeconomic-position-tailored interventions at increasing smoking cessation among smokers with disadvantaged socioeconomic position then these approaches will require redesign. Therefore, we aimed to assess whether the effectiveness of individual-level smoking cessation interventions for disadvantaged groups was moderated by socioeconomic position tailoring.

Methods {#cesec20}
=======

Search strategy and selection criteria {#cesec30}
--------------------------------------

This systematic review and meta-regression followed PRISMA guidelines.[@bib25] We searched MEDLINE, PsycINFO, Embase, Cochrane Central Register, and Tobacco Addiction Register of Clinical Trials and the IC-SMOKE database[@bib26] from their inception until Aug 18, 2019, for randomised controlled trials,[@bib27] published in English, of socioeconomic-position-tailored and non-socioeconomic-position-tailored individual-level behavioural interventions for smoking cessation in disadvantaged groups. The following search terms were used: smoking cessation or smok\* quit\* or smok\* stop\* or smok\* cease or smok\* cessat\* or smok\* give up (title and abstract); RCT or randomi?ed controlled trial or trial or randomi?ed or controlled clinical trial or pragmatic clinical trial (title and abstract); behavio\* or behavio?ral support or intervention or counsel\* or brief or support or psychol\* or individual\* or individual-level or behavio?r therapy or cognitive therapy or target\* or adapt\* or tailor\*) not pharma\* (title and abstract); and equity or equity impact or inequalit\* or under-served or under served or underserved or marginali?ed or poor or affluent or disparit\* or SES or socio-economic or socio-economic or depriv\* or disadvant\* social class or occupation or employ or unemploy\* or educat\* or income or poverty or neighbo?r\* (multiple searches).

This meta-analysis is based on individual participant data. Study authors were contacted if data were not available in a published report. Individual participant-level data were extracted from each study to calculate risk ratios (RRs) and 95% CIs. Studies were excluded if they were delivered at the community or population level, did not report differential effects by socioeconomic position, did not report smoking cessation outcomes from 6 months or longer after the start of the intervention, were delivered at a group level, or provided pharmacotherapy with standard behavioural support compared with behavioural support alone,[@bib28] because pharmacotherapy itself cannot be tailored to socioeconomic position. However, studies in which pharmacotherapy was given to both the intervention and control groups in addition to a behavioural intervention or control or usual care were included.

LK did the literature search. LK and CS independently screened all abstracts. LK screened all full-text articles and CS screened 10% of full-text articles. Inter-rater reliability at abstract screening (Cohen\'s κ=0·81) and full study screening (Cohen\'s κ=0·78) were high. Data were extracted by LK. To check reliability, 10% of data extraction was done independently by HT-B. Percentage agreement was more than 98% after comparison ([appendix pp 7--8](#sec1){ref-type="sec"}). Conflicts over inclusion and data extraction were resolved through discussion. LK and HT-B independently assessed the risk of bias and certainty of evidence using the Cochrane risk-of-bias tool version 2 and the GRADE approach[@bib29] ([appendix pp 2--3](#sec1){ref-type="sec"}). The study [protocol is available online](https://osf.io/2z6cg/){#interrefs10}.

Data analysis {#cesec40}
-------------

Duplicate papers reporting data from the same trial were identified and the secondary papers were excluded before data extraction. We extracted data on study type and setting, participant characteristics, intervention details, and smoking cessation outcomes (both self-reported and biochemically verified using expired carbon monoxide or salivary cotinine)[@bib30] in a customised data extraction form available online.

Diverse interventions, settings, and participants characterise the field of smoking cessation. We judged it likely that the included studies would show heterogeneity in treatment effect (the observed intervention effects being more different from each other than one would expect because of random error alone). As such, the assumptions of a fixed-effect meta-analysis (that all studies in the meta-analysis share a common overall effect size and that all factors that could influence the effect size are the same across studies),[@bib31] were unlikely to hold. Each study included in this review provides information about a different effect size for smoking cessation. In a random-effects model, the aim is to estimate the mean of a distribution of effects without being overly influenced by any individual study.[@bib32] Therefore, each study is weighted by the inverse of both its within-study and between-study variance ([appendix pp 3--4](#sec1){ref-type="sec"}). The SE of the summary effect is calculated as the square root of this variance.

In random-effects meta-analysis models (restricted maximum-likelihood method),[@bib33] we calculated pooled RRs with 95% CIs for both socioeconomic-position-tailored and non-socioeconomic-position-tailored interventions as the weighted average of each individual study\'s estimated intervention effect. All computations were done on a log scale with the log RR, its variance, and SE, before exponentiating the summary effect for interpretation.

We explored heterogeneity by observation of forest plots and use of the χ^2^ test to show whether observed differences in results were compatible with chance alone. We calculated *I*^2^ statistics to examine the level of inconsistency across study findings.[@bib32] *I*^2^ values reflect the degree of overlap of CIs, with lower values indicating that any observed variance is spurious and higher values suggesting that there are real differences in effect size between studies. Publication bias was assessed using funnel plots. Where visual inspection indicated potential funnel plot asymmetry, we did Egger\'s regression test to investigate this.[@bib26] Our analysis followed an intention-to-treat protocol, whereby participants lost to follow-up were classified as continuing to smoke.

We made the following comparisons using forest plots: individual-level interventions (tailored and not tailored to socioeconomic position) versus passive or active control or usual care; socioeconomic-position-tailored individual-level interventions versus passive or active control or usual care; and non-socioeconomic-position-tailored individual-level interventions (subgroups of low socioeconomic position and high socioeconomic position participants) versus passive or active control or usual care.

A conventional meta-analysis attempts to combine results from studies to elucidate a single summary effect size, but diversity in populations and methods among studies often leads to statistical heterogeneity in the true effects of these studies. Meta-regression acts to extend subgroup analyses and allows, in principle, the effects of multiple factors to be investigated simultaneously. Therefore, in contrast to a meta-analysis, meta-regression aims to relate the size of effect to one or more characteristics of the studies involved. In meta-regression, a pooled effect estimate is predicted based on the values of one or more explanatory study-level variables that might influence the size of the intervention effect.[@bib34] Given a sufficient number of trials (ten studies for each covariate can be sufficient),[@bib34] we used unadjusted and adjusted mixed-effects meta-regression analyses to assess whether variation among studies in smoking cessation effect size was moderated by tailoring of the intervention for disadvantaged groups. The resulting regression coefficient indicates how the outcome variable (log RR for smoking cessation) changes when interventions take a socioeconomic-position-tailored versus non-socioeconomic-tailored approach. A statistically significant (p\<0·05) coefficient indicates that there is a linear association between the effect estimate for smoking cessation and the explanatory variable. More moderators (study-level variables) can be included in the model, which might account for part of the heterogeneity in the true effects. We pre-planned an adjusted model to include important study covariates related to the intensity and delivery of the intervention (number of sessions delivered (above median *vs* below median), whether interventions involved a trained smoking cessation specialist (yes *vs* no), and use of pharmacotherapy in the intervention group (yes *vs* no). These covariates were included a priori as potential confounders given that programmes tailored to socioeconomic position might include more intervention sessions or components or be delivered by different professionals with varying experience. The regression coefficient estimates how the intervention effect in the socioeconomic-position-tailored subgroup differs from the reference group of non-socioeconomic-position-tailored interventions. The true effect for smoking cessation (θi) in the adjusted meta-regression is given by $$\begin{matrix}
{\theta\text{i} = \beta_{0} + \beta_{1}\text{SEP} - \text{tailored}_{i} + \beta_{2}\text{SCS}_{i} + \beta_{3}\text{pharmacotherapy}_{i}} \\
{+ \beta_{4}\text{number\ of}\text{sessions}_{i} + ɛ_{\text{k}} + \zeta_{\text{k}}} \\
\end{matrix}$$where β are the regression coefficients, SEP is socioeconomic position, SCS is smoking cessation specialist, ɛ~k~ is the sampling error through which the effect size of the study deviates from the true effect, and ζ~k~ indicates that the true effect size of the study is sampled from an overall distribution of effect sizes.

Where a non-significant (p\>0·05) association between socioeconomic position tailoring and intervention effectiveness was found, we used sensitivity analyses using Bayes factors to examine whether the association reflected evidence of no effect, evidence of an effect, or whether the data were insensitive to detection of an effect.[@bib35], [@bib36]

We calculated further exploratory unadjusted univariate and adjusted models to explore the extent to which important study characteristics could explain anticipated heterogeneity in the study estimates.

Analyses were done in the RStudio development environment version 1.1.463 using R version 3.5.2 and the metafor package.[@bib37] Calculation of Bayes factors was done with an online [calculator](http://www.lifesci.sussex.ac.uk/home/Zoltan_Dienes/inference/Bayes.htm){#interrefs20}. The study is registered with PROSPERO, CRD42018103008.

Role of the funding source {#cesec50}
--------------------------

The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Results {#cesec60}
=======

Of 2376 studies identified by our literature search, 348 full-text articles were retrieved and screened for eligibility. Of these, 42 studies (26 168 participants) were included in the systematic review ([figure 1](#fig1){ref-type="fig"}; [table 1](#tbl1){ref-type="table"}). 26 (62%) of 42 studies were trials of socioeconomic-position-tailored interventions and 16 (38) were non-socioeconomic-position-tailored interventions. Measures of socioeconomic position used by studies varied ([table 1](#tbl1){ref-type="table"}).Figure 1Study selectionTable 1Study characteristics**CountryStudy designSEP tailoringSample SEPWomenMean age, yearsNumber randomisedIntention to quitCigarettes per day, mean (95% CI)Intervention conditionControl conditionPharmacotherapyOutcomeFollow-upBiochemical verificationSEP measure**Abroms at al, 2014[@bib38]USATwo-group RCTNo21·9% high school or lower66%38503No17·3 (13·9--20·7)Text message smoking cessation programmeLink to Smokefree.gov websiteNone30-day point prevalence6 monthsYesEducationAndrews et al, 2016[@bib39]USATwo-group RCTYes79·4% \<US\$20 000 per year100%42200Yes12·7 (7·9--17·6)Face-to-face individual and group support plus NRTWritten materialsNRT7-day point prevalence6 monthsYesIncomeBaker et al, 2018[@bib40]USATwo-group RCTNoMedicaid registered100%261014YesNot reportedHigh financial incentive plus counsellingLow financial incentive plus counsellingNone7-day point prevalence6 months post-birthYesWelfare statusBerndt et al, 2017[@bib41]NetherlandsThree-group RCTNo41·8% primary and basic vocational46%56625No21·1 (17·8--24·4)Telephone and face-to-face counsellingUsual careNRT12-month continued abstinence12 monthsYesEducationBonevski et al, 2018[@bib42]AustraliaTwo-group pragmatic RCTYes94% on state benefits49%38431No15 (11·5--18·5)Brief advice and motivational interviewingOn-screen advice to quit, quitline numberNRT6-month continued abstinence6 monthsYesWelfare statusBrooks et al, 2018[@bib43]USATwo-group cluster-randomised trialYesPublic housing resident74%Not reported331YesNot reportedMotivational interviewing plus NRT offerWritten materials plus brief advice, NRT offerNRT offered7-day and 30-day point prevalence12 monthsYesHousing tenureBrown et al, 2014[@bib44]UKTwo-group RCTYes46·4% long-term unemployed or routine and manual occupation63%394613Yes18·6 (17·5--19·7)An interactive website interventionStatic website with brief adviceNone6-month continued abstinence6 monthsYesOccupationChoi et al, 2014[@bib45]USATwo-group RCTYes61·1% high school or less20%42145No21·0 (14·0--28·0)Website plus telephone support and NRTTelephone support and NRTNRT7-day point prevalence6 monthsYesEducationCurry et al, 2003[@bib46]USATwo-group RCTYes43·2% \<US\$10 000 per year100%34303No12·1 (8·26--15·9)Motivational interviewing plus telephone supportUsual careNone7-day point prevalence12 monthsNoIncomeDavis et al, 2014[@bib47]USATwo-group RCTYes49·5% high school or less50%42196YesNot reportedMindfulness training plus NRTTelephone support plus NRTNRT7-day point prevalence6 monthsYesEducationDanan et al, 2018[@bib48]USATwo-group RCTNo49·5% high school or less5%602430No≤10=36%, 11--20=42%, ≥21=22%Proactive outreach with offer of telephone counselling or referral to in-person counsellingUsual careNRT, buproprion, or varenicline available6-month continued abstinence6 monthsNoEducationEtter and Schmid, 2016[@bib49]SwitzerlandTwo-group RCTNo18% unemployed50%32805Yes16·0 (13·4--18·6)Written materials, website access, and escalating financial rewardsWritten materials plus website accessNone12-month continued abstinence6 monthsYesOccupationFraser et al, 2017[@bib50]USATwo-group RCTYesMedicaid registered61%451900No17·2 (15·5--18·9)Telephone support plus extra financial incentiveTelephone support plus financial incentiveNone7-day point prevalence6 monthsYesWelfare statusFree et al, 2011[@bib51]UKTwo-group RCTNo31% manual occupation45%375800YesNot reportedText messaging smoking cessation programmeText messages unrelated to quittingNone6-month continued abstinence6 monthsYesOccupationFroelicher et al, 2010[@bib52]USATwo-group RCTYes58·3% \<US\$15 000 per year73%4760No11·3 (2·5--20·1)Face-to-face support plus industry and media messagingFace-to-face supportUnclear7-day point prevalence6 monthsYesIncomeFu et al, 2016[@bib53]USATwo-group RCTYesMedicaid registered71%Not reported2406No13·6 (12·2--15·0)Usual care plus proactive telephone and written outreach and NRTUsual careNRT12-month continued abstinence12 monthsNoWelfare statusGlasgow et al, 2000[@bib54]USATwo-group RCTNo42·7% high school or less100%241154No12·0 (10·1--13·9)Brief behavioural support and clinician adviceWritten materials and adviceNone30-day point prevalence6 monthsYesIncomeGordon et al, 2010[@bib55]USATwo-group RCTYesAt or below 200% of US federal poverty level58%412637NoNot reportedBrief advice and assistance and NRTUsual careNRT6-month continued abstinence7·5 monthsNoIncomeHaas et al, 2015[@bib56]USATwo-group RCTYes62·3% medical or medicare recipient69%50707No15·0 (12·3--17·7)Telephone support plus NRTUsual careNRT7-day point prevalence9 monthsNoWelfare statusYilmaz et al, 2006[@bib57]TurkeyThree-group RCTNo50·5% \<US\$250 per month100%Not reported363No6·30 (3·67--8·94)General health information, child and mother health risks, and bookletGeneral health informationNone7-day point prevalence6 monthsNoIncomeKendzor et al, 2012[@bib58]USATwo-group RCTNo61·1% unemployed52%42379NoNot reportedStandard care plus intervention delivered using palmtop computerSelf-help materials plus counselling and NRTNRT30-day point prevalence6 monthsYesEmploymentLasser et al, 2017[@bib59]USATwo-group RCTNo55% \<US\$20 000 per year54%50352Yes15 (11·1--18·9)Enhanced usual care (face-to-face support plus written materials and information on local cessation resources)Usual care (face-to-face support)NRT offered7-day point prevalence12 monthsYesIncomeLepore et al, 2018[@bib60]USATwo-group RCTYes78·7% income below poverty level84%33327No11·5 (7·85--15·1)Face-to-face and telephone supportNutrition interventionNone7-day point prevalence12 monthsYesIncomeLou et al, 2013[@bib61]ChinaTwo-group RCTNoMean income \$US3015 per year52%Not reported3562NoNot reportedGeneral practioner face-to-face supportUsual careNone6-month continued abstinence30 monthsYesIncomeMarks and Sykes, 2002[@bib62]UKTwo-group RCTNo37% unemployedNot reportedNot reported260NoNot reportedEnhanced written materials packageWritten materialsNone7-day point prevalence12 monthsYesIncomeMcClure et al, 2018[@bib63]USATwo-group RCTYes62·6% \<US\$20 000 per year62%44718No19·1 (16·2--22·0)Telephone support, written materials, and oral health interventionTelephone support plus written materialsNRT offered7-day point prevalence12 monthsNoIncomeMundt et al, 2019[@bib64]USATwo-group RCTYesMedicaid registered60%451900No17·2 (15·5--18·9)Financial incentive for taking offered counselling callsOffer of counselling callsOffered7-day point prevalence6 monthsYesWelfare statusNohlert et al, 2009[@bib65]SwedenTwo-group RCTNo23% 0--9 years education80%Not reported300NoNot reported as meanMultiple face-to-face support sessionsOne face-to-face support session and written materialsNone7-day point prevalence12 monthsNoEducationOkuyemi et al, 2007[@bib66]USATwo-group cluster-randomised trialNoPublic housing resident72%46174No17·5 (11·6--23·4)Face-to-face and written materials addressing smoking cessation plus NRTFace-to-face and written materials addressing nutritionNRT7-day point prevalence6 monthsYesHousing tenurePbert et al, 2004[@bib67]USATwo-group cluster-randomised trialYes46·7% less than high school100%26609No16·7 (13·6--19·7)Face-to-face support and written materialsUsual careNone7-day point prevalence6 months post-birthYesIncomeProkhorov et al, 2008[@bib68]USATwo-group RCTYesCommunity college students59%23426No12·5 (9·2--15·7)Computer-assisted support and motivational interviewingBrief face-to-face support and written materialsNone7-day point prevalence10 monthsYesIncomeRash et al, 2018[@bib69]USATwo-group RCTYesHomeless26%4570Yes15·4 (6·2--24·6)Standard care plus financial incentivesFace-to-face counsellingNRT7-day point prevalence6 monthsYesHousing tenureRuger et al, 2008[@bib70]USATwo-group RCTYesMedicaid registered100%26302NoNot reportedMotivational interviewing and relapse prevention supportUsual careNone30-day point prevalence6 months post-birthYesWelfare statusSarkar et al, 2017[@bib71]IndiaTwo-group cluster-randomised trialYes75·9% \<US\$70 per month20%461213NoNot reportedBrief face-to-face support and breathing exercisesVery brief adviceNone6-month continued abstinence7 monthsYesIncomeSheffer et al, 2017[@bib72]USATwo-group RCTYes56·8% \<US\$10 000 per year19%48256Yes13·8 (9·4--18·2)Enhanced standard care: SEP-tailored face-to-face cognitive behavioural treatment for tobacco dependence, NRTFace-to-face cognitive behavioural treatment for tobacco dependence, NRTNRT7-day point prevalence6 monthsYesSEP (income and education)Solomon et al, 2005[@bib73]USATwo-group RCTYesMedicaid registered100%34330Yes23·6 (18·9--28·3)Proactive telephone support plus pharmacotherapyPharmacotherapyNRT7-day and 30-day point prevalence6 monthsNoWelfare statusSolomon et al, 2000[@bib74]USATwo-group RCTYesMedicaid registered100%33214Yes23·7 (17·7--30·0)Proactive telephone support plus pharmacotherapyPharmacotherapyNRT7-day point prevalence6 monthsYesWelfare statusSorensen et al, 2007[@bib75]USATwo-group RCTYesRoutine and manual occupation6%41674NoNot reportedTelephone delivered motivational interviewing, tailored written materials, and NRTWritten materialsNRT offered7-day point prevalence6 monthsNoOccupationStanczyk et al, 2016[@bib76]NetherlandsThree-group RCTNo33·6% low education62%452099Yes18·9 (17·2--20·6)Text and internet-based interventionGeneral adviceNone12-month continued abstinence12 monthsYesEducationStanton et al, 2004[@bib77]AustraliaTwo-group RCTYesUndefined lower SEP (public hospital setting)0Not reported561NoNot reportedSmoking cessation video plus NRTWritten materialsNRTNot reported6 monthsYesEducation or occupationStrecher et al, 2008[@bib78]USATwo-group RCTNo36·2% high school or less60%Not reported1866YesNot reportedHigh-depth website intervention plus NRTLow-depth website intervention plus NRTNRT7-day point prevalence6 monthsNoEducationVidrine et al, 2019[@bib79]USAThree-group RCTNo70% high school or less51%49624Yes≤10=30%, 11--20=46%, ≥21=24%NRT plus text and telephone callsNRT aloneNRT30-day point prevalence6 monthsYesEducation[^1]

30 (71%) of 42 studies were done in the USA,^38--40,43,45--48,50,52--56,58--60,63,64,66--70,72--75,78,79^ three (7%) were done in the UK,[@bib44], [@bib51], [@bib62] two (5%) each in the Netherlands[@bib41], [@bib76] and Australia,[@bib42], [@bib77] and one (2%) each in Switzerland,[@bib49] Sweden,[@bib65] Turkey,[@bib57] India,[@bib71] and China.[@bib61]

Ten studies recruited participants during hospital or clinic visits related to general health, cardiac health, dental health, or the health of a participant\'s child.^41,46,54,55--57,59,60,65,77^ Nine studies recruited only women.[@bib39], [@bib40], [@bib46], [@bib54], [@bib57], [@bib67], [@bib70], [@bib74], [@bib79] Three studies exclusively included pregnant women[@bib40], [@bib67], [@bib70] and one study recruited only men whose partners were pregnant.[@bib77] White participants were the majority in 23 studies^38,40,44,45,47,48,51,53,54,56,62,63,65,67--71,73--77^ and African American participants were the majority in 12 studies.[@bib39], [@bib43], [@bib46], [@bib50], [@bib52], [@bib55], [@bib58], [@bib59], [@bib60], [@bib64], [@bib66], [@bib79] One study recruited only Chinese participants,[@bib61] and another only Indian participants.[@bib71]

In-person or telephone support typically included one or more sessions with a health professional who assisted in the quit attempt. These professionals included clinicians, nurses, or health educators, who either provided smoking cessation support as part of their job or worked as a smoking cessation specialist. Digital behavioural support involved interactive and tailored smoking cessation support delivered via text messages, or on a website or page accessible on a computer or other device. Financial incentive condition participants received incentives that were conditional upon them attending support sessions or health visits or contingent upon biochemically validated smoking abstinence at follow-up. Brief interventions consisted of brief advice and assistance related to smoking cessation and outlined general health risks from smoking.

Overall, six (14%) of 42 included studies were classified as being at low risk of bias on all domains considered in the assessment ([appendix pp 2--3](#sec1){ref-type="sec"}).

A pooled effect size was estimated based on the 42 studies of socioeconomic-position-tailored and non-socioeconomic-position-tailored individual-level interventions in groups with low socioeconomic position ([figure 2](#fig2){ref-type="fig"}). Individuals with low socioeconomic position who participated in an intervention were significantly more likely to quit smoking than those with low socioeconomic position in control groups (RR 1·56, 95% CI 1·39--1·75). We found evidence of moderate heterogeneity in the effect size between trials (*I*^2^=54·5%). The certainty of evidence for this comparison was deemed to be moderate. A funnel plot suggested that there was no reporting bias for smoking cessation outcomes ([appendix p 4](#sec1){ref-type="sec"}).Figure 2Individual-level interventions compared with control or usual care in socioeconomically disadvantaged groupsOutcome was smoking cessation at ≥6 months follow-up.

In an unadjusted univariate model, tailoring of interventions for disadvantaged groups was not associated with smoking cessation effect size ([table 2](#tbl2){ref-type="table"}). This absence of association between tailoring of the intervention and intervention effect was also evident in the pre-planned model adjusted for the number of sessions delivered ([table 3](#tbl3){ref-type="table"}; model 1), whether interventions were delivered by a smoking cessation specialist and whether the interventions involved the use of pharmacotherapy. However, we found evidence of some intercorrelation among study characteristics in model 1 ([table 3](#tbl3){ref-type="table"}), whereby interventions that were delivered by a trained specialist generally involved a greater number of sessions. Therefore, we removed the number of sessions covariate and reran the analyses ([table 3](#tbl3){ref-type="table"}; model 2).Table 2Unadjusted univariate associations between intervention factors and effect size of intervention**β (SE)Risk ratio (95% CI)**[\*](#tbl2fn1){ref-type="table-fn"}**p value**I**^2^Adjusted R^2^**Tailored for low socioeconomic position[†](#tbl2fn2){ref-type="table-fn"}−0·02 (0·13)1·02 (0·79--1·32)0·8657·02%0·00%Trained specialist[‡](#tbl2fn3){ref-type="table-fn"}−0·23 (0·12)0·79 (0·63--0·99)0·04850·38%13·65%Pharmacotherapy[§](#tbl2fn4){ref-type="table-fn"}0·27 (0·13)1·31 (1·01--1·68)0·04541·27%41·20%Number of sessions[¶](#tbl2fn5){ref-type="table-fn"}−0·01 (0·12)1·00 (0·78--1·27)0·9956·55%0·00%Active control[‖](#tbl2fn6){ref-type="table-fn"}−0·03 (0·13)0·97 (0·75--1·25)0·8057·21%0·00%Type of support[\*\*](#tbl2fn7){ref-type="table-fn"}−0·26 (0·14)0·77 (0·58--1·02)0·06452·21%3·48%Risk of bias[††](#tbl2fn8){ref-type="table-fn"}−0·33 (0·18)0·72 (0·51--1·02)0·06852·66%5·81%Biochemical verification[‡‡](#tbl2fn9){ref-type="table-fn"}−0·03 (0·13)0·97 (0·74--1·26)0·8057·39%0·00%Intention to quit[§§](#tbl2fn10){ref-type="table-fn"}−0·06 (0·13)0·94 (0·73--1·20)0·6056·28%0·00%[^2][^3][^4][^5][^6][^7][^8][^9][^10][^11]Table 3Adjusted associations between tailoring and effect size of intervention**β (SE)Risk ratio**[\*](#tbl3fn1){ref-type="table-fn"}**(95% CI)p valueModel 1**Tailored for low SEP[†](#tbl3fn2){ref-type="table-fn"}−0·01 (0·12)1·01 (0·80--1·28)0·93Trained specialist[‡](#tbl3fn3){ref-type="table-fn"}−0·28 (0·13)0·76 (0·58--0·98)0·0035Pharmacotherapy[§](#tbl3fn4){ref-type="table-fn"}0·24 (0·14)1·27 (0·96--1·67)0·089Number of sessions[¶](#tbl3fn5){ref-type="table-fn"}0·11 (0·13)1·12 (0·87--1·45)0·38**Model 2**Tailored for low SEP[†](#tbl3fn2){ref-type="table-fn"}0·01 (0·11)1·01 (0·81--1·27)0·93Trained specialist[‡](#tbl3fn3){ref-type="table-fn"}−0·21 (0·11)0·81 (0·65--0·99)0·049Pharmacotherapy[§](#tbl3fn4){ref-type="table-fn"}0·25 (0·13)1·29 (0·99--1·67)0·058[^12][^13][^14][^15][^16][^17]

Based on an expected RR of 1·5, the calculated Bayes factor for model 2 (0·291) indicated weak evidence that tailoring had no effect on intervention effectiveness. Repeating the calculation based on an expected effect size of 1·1 showed that the data were insensitive to detection of small effects (Bayes factor=0·81).

Exploratory unadjusted univariate models showed no evidence of an association between biochemical verification and smoking cessation effect size, but behavioural support (digital or in-person or telephone), studies with some concerns in at least one domain of the Cochrane risk-of-bias tool for this result, but no high risk of bias for any domain, and pharmacotherapy had meaningful associations with effect size ([table 2](#tbl2){ref-type="table"}). An adjusted model including these three variables reduced the heterogeneity in the effect size between trials (*I*^2^=16·55%, R^2^~adjusted~=82·09%; p=0·0027) compared with the result from the primary meta-analysis (*I*^2^=54·50%; [appendix p 5](#sec1){ref-type="sec"}).

We estimated a pooled effect size based on the 26 studies of socioeconomic-position-tailored interventions ([appendix p 5](#sec1){ref-type="sec"}). Smokers with disadvantaged socioeconomic position who participated in a socioeconomic-position-tailored intervention were significantly more likely to quit smoking than were those in the control group (RR 1·54, 95% CI 1·37--1·72) with some evidence of heterogeneity in the effect size between trials (*I*^2^=38·10%).

We estimated pooled effect sizes separately for participants with low socioeconomic position and participants with high economic position based on the 12 studies of non-socioeconomic-position-tailored interventions that reported outcomes ([figure 3](#fig3){ref-type="fig"}). Four non-socioeconomic-position-tailored interventions were excluded from this comparison as they were delivered in a low socioeconomic position context and did not provide outcome data for participants with high socioeconomic position.Figure 3Non-socioeconomic-position-tailored interventions compared with control or usual care in participants with low socioeconomic position (A) and participants with high socioeconomic position (B)

Individuals with low and high socioeconomic position who participated in a non-socioeconomic-position-tailored intervention were significantly more likely to quit smoking than were controls. However, we found evidence of high heterogeneity in the effect size between trials for both the low socioeconomic position and high socioeconomic position subgroups (*I*^2^=76·6% and *I^2^*=82·7%, respectively; [figure 3](#fig3){ref-type="fig"}). The results of our subgroup analysis suggest that there were no differences between the estimates of smoking cessation according to the socioeconomic position of participants ([appendix pp 5--6](#sec1){ref-type="sec"}).

Funnel plots indicated potential reporting bias due to studies suggesting a beneficial effect being more likely to be published than studies showing no effect ([appendix p 6](#sec1){ref-type="sec"}). Egger\'s test for funnel plot asymmetry showed no difference with respect to the low socioeconomic position participant analysis, but a significant difference for the high socioeconomic position analysis ([appendix p 7](#sec1){ref-type="sec"}).

Discussion {#cesec70}
==========

We found consistent evidence that individual-level interventions for smoking cessation in socioeconomically disadvantaged groups are effective for smoking cessation. However, we found no evidence that tailoring interventions for smokers with low socioeconomic position significantly moderated effectiveness compared with non-socioeconomic-position-tailored interventions. Bayes factors indicated that there were no large moderating effects, but that the data were insensitive to detection of smaller moderating effects. This finding was not surprising considering that meta-analyses of non-socioeconomic-position-tailored interventions showed similar effect sizes for smoking cessation in separate models for participants with high socioeconomic position and with low socioeconomic position from the same study. However, the estimates for subgroups should be interpreted with caution given that overall the evidence from these studies was deemed to be of low certainty.

Tailored individual-level approaches are expected to have an important role in reducing health inequalities by addressing some of the needs specific to disadvantaged smokers. However, our results imply that such tailoring has not yet improved effectiveness compared with non-socioeconomic-position-tailored approaches. Nevertheless, such programmes have shown general effectiveness so should not be withdrawn without replacement.[@bib22], [@bib80] To improve the prevalence of smoking cessation among disadvantaged smokers, a new, multifaceted approach is required at the individual, community, and population level. Compared with those with more advantaged socioeconomic position, individuals with low socioeconomic position face more facilitators to smoking uptake and more barriers to quitting,[@bib2] which might outweigh the benefits of tailoring interventions at the individual level.

Comparing results from separate meta-analyses using data from participants with low socioeconomic position and participants with high socioeconomic position from the same trial showed that the effects of non-socioeconomic-position-tailored interventions on smoking cessation were similar in all participants. This finding contrasts with a previous review,[@bib81] which suggested that non-socioeconomic-position-tailored smoking cessation support interventions were likely to be equity negative (helping participants with advantaged socioeconomic position to quit more than disadvantaged participants). However, this divergence should be interpreted with caution as the inclusion criteria between the studies differed. The current systematic review only included randomised controlled trials of individual-level interventions measuring smoking cessation at least 6 months after baseline. The previous review[@bib81] largely focused on face-to-face behavioural support and included observational and correlational designs and randomised controlled trials that involved the use of pharmacotherapy alone. Furthermore, in response to inequalities in access, provision of smoking cessation services in some low-socioeconomic-position areas of the UK has improved, with results from programmes in Scotland indicating improvements in quitting success among disadvantaged smokers.[@bib61] These data support the finding from the current review that non-socioeconomic-position-tailored interventions appear to have a similar effectiveness for quitting smoking success across the social gradient, if access to such services is provided.

Nine studies included in this review recruited women only, whereas one study recruited men only. This focus might be a response to the evidence of higher smoking prevalence and health inequalities among disadvantaged ethnic minority women[@bib25] and the potential opportunity for a smoking cessation intervention when women are in the clinic either during or following pregnancy.

30 studies in our review used point prevalence (7-day or 30-day) rather than continued abstinence outcomes. Although there is some debate as to which is a more robust measure, a 2010 systematic review[@bib82] comparing these two outcome measures concluded that they are highly correlated and produce similar effect sizes for smoking cessation.

This systematic review is not without limitations. Although several covariates were prespecified in the protocol, it was not possible to do the same for all other potentially important covariates and this might result in false-positive conclusions. Therefore, results indicating a reduction in heterogeneity compared with the primary meta-analysis should be viewed as exploratory. Furthermore, study characteristics included in the meta-regression might have been highly correlated, such that an observed association with one study characteristic is in fact reflective of a true association with another correlated characteristic that has not been measured. There was some evidence of clustering of study characteristics, whereby more sessions appeared to take place if a trained specialist was delivering the intervention. It is also possible that the effectiveness of behavioural support depended on the skill of the practitioner delivering it;[@bib83] unfortunately a variable to assess practitioner skill was not available for most studies analysed, so meaningful adjustment for this was not possible. However, such effects are generally relatively small[@bib83] and so unlikely to have overly biased our results. Furthermore, since we included study quality (which measures bias in trials) in the meta-regression, we argue that we attempted to account for therapist effects as far as possible given the available information. Our risk of bias assessment included deviations from the intended interventions. In cases in which the original study provided no information for this factor, the potential bias was noted and included in the final assessment for overall risk of bias. Other measures of effectiveness for smoking cessation in interventions tailored for disadvantaged groups, such as time to relapse and abstinence at earlier follow-up timepoints, might provide a more nuanced picture of study results.

There are potential limitations related to the operationalisation of socioeconomic position in this Article. Although 39 (93%) of 42 studies were done in high-income countries, there are often between-country differences in terms of how socioeconomic position is experienced and how this influences health behaviour.[@bib3] Furthermore, the socioeconomic position of the underlying sample populations in each study might have differed between socioeconomic-position-tailored and non-socioeconomic-position-tailored interventions. Were this true, the apparent effectiveness of non-socioeconomic-position-tailored interventions for smokers with low socioeconomic position discussed in this review might reflect the recruitment of more socioeconomically advantaged participants than in trials of socioeconomic-position-tailored interventions. Trials of non-socioeconomic-position-tailored interventions that report outcomes by socioeconomic position might also differ from non-socioeconomic-position-tailored interventions that do not report this. Such studies might focus more on socioeconomic position issues despite not explicitly reporting on tailoring of the intervention to populations with different socioeconomic positions, which might lead to underestimating the moderating effect of socioeconomic position tailoring. Therefore, future research in this field should consider using a standardised index of socioeconomic position to allow valid comparison between levels of deprivation across populations.

During the study screening process, it became apparent that relevant studies (n=161) might have been excluded because they did not report their outcomes by socioeconomic position, despite potentially having a socioeconomically diverse sample of participants. Given the persistent inequalities in smoking rates worldwide, it is becoming ever more important that smoking cessation trials, where possible, collect and report outcomes by socioeconomic position. Studies are typically not powered for robust subgroup analyses by socioeconomic position, but if outcomes are reported in this way then they can be cumulatively included in pooled effect size estimates in future reviews. The certainty of evidence of studies included in this review was rated as moderate for the primary analysis and low for the secondary analyses. As such, it remains possible that the true effects are different to what was estimated.

Despite these limitations, this study has several strengths. To our knowledge, no previous reviews have examined whether socioeconomic position tailoring moderates the effectiveness of individual-level behavioural smoking cessation interventions at 6 months or later in socioeconomically disadvantaged groups. Inclusion of 42 studies in our systematic review made it possible to do a meta-regression analysis, which is a useful tool to extend the analysis and relate the size of treatment effect in clinically and methodologically diverse studies to relevant study characteristics. Considering the growing number of interventions that involve some form of tailoring for disadvantaged groups, this analysis is an important step towards gathering evidence about their effectiveness and might also encourage further equity-focused research that will improve the effectiveness of smoking cessation programmes. Future research in this area should also consider assessing what the most effective components of socioeconomic-position-tailored interventions are by using an appropriate theory-informed taxonomy.[@bib26], [@bib84]

This systematic review and meta-regression highlights that although both socioeconomic-position-tailored and non-socioeconomic-position-tailored individual-level interventions for smoking cessation in socioeconomically disadvantaged groups are effective for smoking cessation, based on the evidence available for this review, there is currently no evidence for large moderating effects of tailoring for disadvantaged smokers.
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[^1]: SEP=socioeconomic position. RCT=randomised controlled trial. NRT=nicotine replacement therapy.

[^2]: Calculated by exponentiating log-transformed estimates of intervention effect.

[^3]: Socioeconomic-position-tailored *vs* non-socioeconomic-position-tailored intervention.

[^4]: Intervention involved provider trained in smoking cessation *vs* not trained in smoking cessation.

[^5]: Pharmacotherapy delivered *vs* not delivered.

[^6]: Number of sessions delivered in intervention \>4 *vs* ≤4.

[^7]: Active control *vs* inactive control.

[^8]: Digital or face-to-face or telephone intervention *vs* other intervention (financial incentives and brief interventions).

[^9]: High or some concerns over risk of bias *vs* low risk of bias.

[^10]: Biochemically verified smoking cessation *vs* no biochemically verified smoking cessation.

[^11]: Intention to quit *vs* no intention to quit.

[^12]: SEP=socioeconomic position.

[^13]: Calculated by exponentiating log-transformed estimates of intervention effect. Associations after mutual adjustment for all variables listed in this table.

[^14]: SEP-tailored *vs* non-SEP-tailored intervention.

[^15]: Intervention involved provider trained in smoking cessation *vs* not trained in smoking cessation.

[^16]: Pharmacotherapy delivered *vs* not delivered.

[^17]: Number of sessions delivered in intervention \>4 *vs* ≤4.
